valine has been researched along with Opportunistic Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bion, JF; Cowley, NJ; Ives, N; Millar, J; Moss, P; Osman, H; Owen, A; Shiels, SC; Woolley, R | 1 |
| Fedorak, RN; Ma, C; Walters, B | 1 |
| Treister, NS; Villa, A | 1 |
| Kavasoglu, K; Kervan, U; Kocabeyoglu, SS; Kucuker, SA; Ozatik, MA; Pac, M; Sert, DE; Tezer, AY; Unal, EU | 1 |
| Buda, A; Checchin, D; D' Incà, R; Sgarabotto, D; Sturniolo, GC | 1 |
| Reischig, T | 1 |
| Sinnige, HA; Westdorp, H | 1 |
| Legendre, C; Squifflet, JP | 1 |
| Fiddian, P; Griffiths, PD; Sabin, CA | 1 |
| Beaulieu, J; Dworkin, L; Gohh, R; Monaco, A; Morrissey, P; Shemin, D; Yango, A; Zanabli, A | 1 |
| Höglund, M; Ljungman, P; Weller, S | 1 |
4 review(s) available for valine and Opportunistic Infections
| Article | Year |
|---|---|
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.
Topics: Acyclovir; Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; Crohn Disease; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Meningitis, Viral; Opportunistic Infections; Prednisone; Treatment Outcome; Tumor Necrosis Factor-alpha; Valacyclovir; Valine; Virus Activation | 2013 |
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.
Topics: Acyclovir; Antiviral Agents; Clinical Protocols; Cytomegalovirus Infections; Ganciclovir; Humans; Immunosuppressive Agents; Opportunistic Infections; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valganciclovir; Valine | 2012 |
The economic value of valacyclovir prophylaxis in transplantation.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Bone Marrow Transplantation; Cost-Benefit Analysis; Cytomegalovirus Infections; Graft Rejection; Health Care Costs; Heart Transplantation; Humans; Kidney Transplantation; Opportunistic Infections; Postoperative Complications; Prodrugs; Time Factors; Valacyclovir; Valine | 2002 |
Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Graft Rejection; Herpes Simplex; Humans; Odds Ratio; Opportunistic Infections; Organ Transplantation; Postoperative Complications; Prodrugs; Randomized Controlled Trials as Topic; Treatment Outcome; Valacyclovir; Valine | 2002 |
2 trial(s) available for valine and Opportunistic Infections
| Article | Year |
|---|---|
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Critical Illness; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Opportunistic Infections; Respiration, Artificial; Valacyclovir; Valine; Virus Activation; Virus Inactivation | 2017 |
Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Female; Herpes Simplex; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Opportunistic Infections; Valacyclovir; Valine | 2001 |
5 other study(ies) available for valine and Opportunistic Infections
| Article | Year |
|---|---|
Intraoral herpes simplex virus infection in a patient with common variable immunodeficiency.
Topics: Acyclovir; Antiviral Agents; Common Variable Immunodeficiency; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lichen Planus, Oral; Middle Aged; Opportunistic Infections; Stomatitis, Herpetic; Valacyclovir; Valine | 2013 |
Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Opportunistic Infections; Pneumonia, Viral; Risk Factors; Time Factors; Treatment Outcome; Valacyclovir; Valine; Virus Activation; Young Adult | 2016 |
Successful prophylaxis with valaciclovir for relapsing HSV-1 in a girl treated with infliximab for moderate Crohn's disease.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Crohn Disease; Female; Herpesvirus 1, Human; Humans; Infliximab; Opportunistic Infections; Secondary Prevention; Valacyclovir; Valine; Virus Activation | 2009 |
A patient with haemorrhagic bullae. Varicella zoster virus (VZV).
Topics: Acyclovir; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Blister; Hemorrhage; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunologic Factors; Male; Opportunistic Infections; Purpura, Thrombocytopenic, Idiopathic; Rituximab; Valacyclovir; Valine | 2012 |
Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Preoperative Care; Probability; Retrospective Studies; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2003 |